Index
1 Market Overview of Neuromodulators Injectable
1.1 Neuromodulators Injectable Market Overview
1.1.1 Neuromodulators Injectable Product Scope
1.1.2 Neuromodulators Injectable Market Status and Outlook
1.2 Global Neuromodulators Injectable Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Neuromodulators Injectable Market Size by Region (2018-2029)
1.4 Global Neuromodulators Injectable Historic Market Size by Region (2018-2023)
1.5 Global Neuromodulators Injectable Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Neuromodulators Injectable Market Size (2018-2029)
1.6.1 North America Neuromodulators Injectable Market Size (2018-2029)
1.6.2 Europe Neuromodulators Injectable Market Size (2018-2029)
1.6.3 Asia-Pacific Neuromodulators Injectable Market Size (2018-2029)
1.6.4 Latin America Neuromodulators Injectable Market Size (2018-2029)
1.6.5 Middle East & Africa Neuromodulators Injectable Market Size (2018-2029)
2 Neuromodulators Injectable Market by Type
2.1 Introduction
2.1.1 Botulinum Toxin
2.1.2 Hyaluronic Acid
2.1.3 Calcium Hydroxylapatite
2.1.4 Poly-l-Lactic Acid
2.1.5 Others
2.2 Global Neuromodulators Injectable Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Neuromodulators Injectable Historic Market Size by Type (2018-2023)
2.2.2 Global Neuromodulators Injectable Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Neuromodulators Injectable Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Neuromodulators Injectable Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Neuromodulators Injectable Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Neuromodulators Injectable Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Neuromodulators Injectable Revenue Breakdown by Type (2018-2029)
3 Neuromodulators Injectable Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Dermatology Clinics
3.1.3 Spas and Aesthetic Clinics
3.2 Global Neuromodulators Injectable Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Neuromodulators Injectable Historic Market Size by Application (2018-2023)
3.2.2 Global Neuromodulators Injectable Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Neuromodulators Injectable Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Neuromodulators Injectable Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Neuromodulators Injectable Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Neuromodulators Injectable Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Neuromodulators Injectable Revenue Breakdown by Application (2018-2029)
4 Neuromodulators Injectable Competition Analysis by Players
4.1 Global Neuromodulators Injectable Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuromodulators Injectable as of 2022)
4.3 Date of Key Players Enter into Neuromodulators Injectable Market
4.4 Global Top Players Neuromodulators Injectable Headquarters and Area Served
4.5 Key Players Neuromodulators Injectable Product Solution and Service
4.6 Competitive Status
4.6.1 Neuromodulators Injectable Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 ALLERGAN
5.1.1 ALLERGAN Profile
5.1.2 ALLERGAN Main Business
5.1.3 ALLERGAN Neuromodulators Injectable Products, Services and Solutions
5.1.4 ALLERGAN Neuromodulators Injectable Revenue (US$ Million) & (2018-2023)
5.1.5 ALLERGAN Recent Developments
5.2 Merz Pharma
5.2.1 Merz Pharma Profile
5.2.2 Merz Pharma Main Business
5.2.3 Merz Pharma Neuromodulators Injectable Products, Services and Solutions
5.2.4 Merz Pharma Neuromodulators Injectable Revenue (US$ Million) & (2018-2023)
5.2.5 Merz Pharma Recent Developments
5.3 Suneva Medical
5.3.1 Suneva Medical Profile
5.3.2 Suneva Medical Main Business
5.3.3 Suneva Medical Neuromodulators Injectable Products, Services and Solutions
5.3.4 Suneva Medical Neuromodulators Injectable Revenue (US$ Million) & (2018-2023)
5.3.5 Medytox Recent Developments
5.4 Medytox
5.4.1 Medytox Profile
5.4.2 Medytox Main Business
5.4.3 Medytox Neuromodulators Injectable Products, Services and Solutions
5.4.4 Medytox Neuromodulators Injectable Revenue (US$ Million) & (2018-2023)
5.4.5 Medytox Recent Developments
5.5 Sinclair Pharma
5.5.1 Sinclair Pharma Profile
5.5.2 Sinclair Pharma Main Business
5.5.3 Sinclair Pharma Neuromodulators Injectable Products, Services and Solutions
5.5.4 Sinclair Pharma Neuromodulators Injectable Revenue (US$ Million) & (2018-2023)
5.5.5 Sinclair Pharma Recent Developments
5.6 Bloomage BioTechnology Corporation Limited
5.6.1 Bloomage BioTechnology Corporation Limited Profile
5.6.2 Bloomage BioTechnology Corporation Limited Main Business
5.6.3 Bloomage BioTechnology Corporation Limited Neuromodulators Injectable Products, Services and Solutions
5.6.4 Bloomage BioTechnology Corporation Limited Neuromodulators Injectable Revenue (US$ Million) & (2018-2023)
5.6.5 Bloomage BioTechnology Corporation Limited Recent Developments
5.7 Anika Therapeutics
5.7.1 Anika Therapeutics Profile
5.7.2 Anika Therapeutics Main Business
5.7.3 Anika Therapeutics Neuromodulators Injectable Products, Services and Solutions
5.7.4 Anika Therapeutics Neuromodulators Injectable Revenue (US$ Million) & (2018-2023)
5.7.5 Anika Therapeutics Recent Developments
5.8 Galderma
5.8.1 Galderma Profile
5.8.2 Galderma Main Business
5.8.3 Galderma Neuromodulators Injectable Products, Services and Solutions
5.8.4 Galderma Neuromodulators Injectable Revenue (US$ Million) & (2018-2023)
5.8.5 Galderma Recent Developments
5.9 Bausch Health Companies
5.9.1 Bausch Health Companies Profile
5.9.2 Bausch Health Companies Main Business
5.9.3 Bausch Health Companies Neuromodulators Injectable Products, Services and Solutions
5.9.4 Bausch Health Companies Neuromodulators Injectable Revenue (US$ Million) & (2018-2023)
5.9.5 Bausch Health Companies Recent Developments
5.10 Integra Lifesciences
5.10.1 Integra Lifesciences Profile
5.10.2 Integra Lifesciences Main Business
5.10.3 Integra Lifesciences Neuromodulators Injectable Products, Services and Solutions
5.10.4 Integra Lifesciences Neuromodulators Injectable Revenue (US$ Million) & (2018-2023)
5.10.5 Integra Lifesciences Recent Developments
6 North America
6.1 North America Neuromodulators Injectable Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Neuromodulators Injectable Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neuromodulators Injectable Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neuromodulators Injectable Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neuromodulators Injectable Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neuromodulators Injectable Market Dynamics
11.1 Neuromodulators Injectable Industry Trends
11.2 Neuromodulators Injectable Market Drivers
11.3 Neuromodulators Injectable Market Challenges
11.4 Neuromodulators Injectable Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List